This concept is supported by findings in patients undergoing percutaneous transhepatic biliary drainage, who showed increased biliary phospholipid secretion after treatment with bezafibarte,183 although the same study reported that patients with PBC had already increased MDR3 expression that was not further upregulated by bezafibrate treatment. This evidence concerns the gene ABCB4 and primary biliary cholangitis.